81 78 265 0500
Sysmex Corporation, together with its subsidiaries, engages in the research and development, production, sale, service, and support of in-vitro diagnostic instruments, peripheral devices, reagents, and related software for the use in hematology, urinalysis, immunochemistry, clinical chemistry, and hemostasis worldwide. It also offers urine formed sediment analysis system that measures red blood cells, white blood cells, and other formed elements in the urine; La-vietal LS, a clinical testing instrument system that links clinical testing instruments and other systems to provide an efficient operating environment; automated immunoassay and clinical chemistry analyzers; and coagulation analyzers for hemostasis. In addition, the company provides systems for the detection of lymph node metastasis of colon and stomach cancer, as well as breast cancer; and Curebest 95GC Breast, a gene expression analysis assay service that offers research data for the prediction of the recurrence of breast cancer. Further, it offers ASTRIM FIT, a non-invasive blood vessel monitor measures hemoglobin concentrations and blood-vessel width through near-infrared spectroscopic images by placing a finger on the detector, as well as develops and sells software for diagnostic information systems. Additionally, the company provides facility management services, marketing related to the commercialization of medical robots, and genetic analysis services, as well as imports, sells, and repairs medical instruments. It serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.